A prescription for drug shortages

JAMA

Volumn 307, Issue 2, 2012, Pages 153-154

  Gehrett, Barbara K ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; ETOMIDATE; GENERIC DRUG; ORPHAN DRUG; PROPOFOL;

CRYSTALLIZATION; DRUG CONTROL; DRUG COST; DRUG INFORMATION; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG RECALL; DRUG USE; FOOD AND DRUG ADMINISTRATION; PATENT; PRESCRIPTION; PRIORITY JOURNAL; SHELF LIFE; SHORT SURVEY;

EID: 84855677357     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.2000     Document Type: Short Survey

References (8)

1. Testimony of Dr. Howard K. Koh, Assistant Secretary of Health, US Department of Health and Human Services. Examining the Increase in Drug Shortages. Presented before the Subcommittee on Health of the Energy and Commerce Committee of the US House of Representatives, September 23, 2011. http://republicans.energycommerce.house.gov/Media/file/Hearings/Health/ 092311%20Drug%20Shortages/Kohtestimony.pdf. Accessed November 5, 2011.
2. Fox E; University of Utah Drug Information Service. Update on the Status of Drug Shortages, Causes, and Significant Trends. Presented at the Drug Shortage Workshop sponsored by the Food and Drug Administration, September 26, 2011. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM275801.pdf. Accessed November 5, 2011.
3. Cherici C, Frazier J, Feldman M, et al. Navigating Drug Shortages in American Healthcare: A Premier Healthcare Alliance Analysis. http://www.premierinc.com/about/news/11-mar/drug-shortage-white-paper-3-28-11. pdf. Accessed November 5, 2011.
4. Jensen V, Rappaport BA. The reality of drug shortages: the case of the injectable agent propofol. N Engl J Med. 2010;363(9):806-807.
5. American Society of Health-System Pharmacists. Drug Shortages: Current Drugs. http://www.ashp.org/DrugShortages/Current/. Accessed November 5, 2011.
6. Davenport-Ennis N; National Patient Advocacy Foundation. Improving Patient Care with Regulatory and Policy Initiatives. Presented at the Drug Shortage Workshop sponsored by the Food and Drug Administration, September 26, 2011. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM275801.pdf. Accessed November 5, 2011.
7. McBride A. Hematology/Oncology Pharmacy Association. Presented at the Drug Shortage Workshop sponsored by the Food and Drug Administration, September 26, 2011. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM275801.pdf. Accessed November 5, 2011.
8. US Department of Health and Human Services. ASPE Issue Brief: Economic Analysis of the Causes of Drug Shortages. http://aspe.hhs.gov/sp/reports/2011/ DrugShortages/ib.shtml. Accessed November 5, 2011.